Jump to main content
eTG Complete
Index
Search
Home
Rheumatology
Rheumatoid arthritis
Pharmacological management for rheumatoid arthritis
Rheumatology
Assessment and initial management of musculoskeletal symptoms
Practical information on drugs used for musculoskeletal and rheumatological conditions
Adult-onset Still disease
Antiphospholipid syndrome
Autoinflammatory periodic fever syndromes
Back pain
Behçet syndrome
Crystal diseases including gout
Fibromyalgia
Idiopathic inflammatory myopathies
Immunoglobulin G
4
-related disease
Inflammatory connective tissue diseases
Juvenile idiopathic arthritis
Overview of limb conditions
Upper limb conditions
Lower limb conditions
Neck pain
Osteoarthritis
Musculoskeletal conditions in children and adolescents
Polymyalgia rheumatica
Pregnancy-related low back pain and pelvic pain
Raynaud phenomenon
Rheumatoid arthritis
Overview of rheumatoid arthritis
Diagnosis of rheumatoid arthritis
Management for rheumatoid arthritis
Pharmacological management for rheumatoid arthritis
Induction and maintenance of clinical remission in rheumatoid arthritis
Using a ‘treat-to-target’ approach aiming for clinical remission in rheumatoid arthritis
Conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) for treatment of rheumatoid arthritis
Systemic corticosteroids for management of rheumatoid arthritis
Biological and targeted-synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) for management of rheumatoid arthritis
Monitoring disease activity in rheumatoid arthritis
Pain management in rheumatoid arthritis
Management for comorbidities associated with rheumatoid arthritis
Monitor for adverse effects of drug therapy
Stopping tobacco smoking in patients with rheumatoid arthritis
Management for fatigue associated with rheumatoid arthritis
Physical activity and exercise for patients with rheumatoid arthritis
Diet for patients with rheumatoid arthritis
References
Spondyloarthritis
Systemic vasculitides
Transition of adolescents to adult rheumatology management
Viral arthritis
Pharmacological management for rheumatoid arthritis
Induction and maintenance of clinical remission in rheumatoid arthritis
Using a ‘treat-to-target’ approach aiming for clinical remission in rheumatoid arthritis
Conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) for treatment of rheumatoid arthritis
Systemic corticosteroids for management of rheumatoid arthritis
Biological and targeted-synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) for management of rheumatoid arthritis
